Home > Publications & Reports > 2005
 
 
 
 
 
| 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 |
| 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 |

2005

  1. Abdulmajeed A, Shapiro J, Rivers JK, MacDonald N, Wiggin J, Lui H. Paradoxical hypertrichosis after laser epilation. J Am Acad Dermatol 2005; 53-85.
  2. Ball NJ, Kho GT. Melanocytic nevi are associated with neurofibromas in neurofibromatosis, type I, but not sporadic neurofibromas: A study of 226 cases. J Cutan Path 2005;32, 523-532.
  3. Carruthers A, Carruthers JC. Botulinum toxin type A. J Am Acad Dermatol 2005; 53-284.
  4. Carruthers A, Carruthers JC. Dose-Ranging Study of Botulinum Toxin Type A in the Treatment of Glabellar Rhytids in Females. J Am Acad Dermatol 2005; 53: 284-90.
  5. Carruthers A, Carruthers JC. Single-Center, Double-Blind, Randomized Study to Evaluate the Efficacy of 4% Lidocaine Cream versus Vehicle Cream During Botulinum Toxin Type A Treatments. Dermatol Surg 2005; 31, 1655-1659.
  6. Carruthers J, Klein A, Carruthers A, Glogau R, Canfield D. Safety and Efficacy of Nonanimal Stabilized Hyaluronic Acid for Improvement of Mouth Corners. Dermatol Surg 2005; 31, 276-280.
  7. Chin MY, Ng KCP, Li G. The novel tumor suppressor p33ING2 enhances UVB-induced apoptosis in human melanoma cells. Exp Cell Res 2005; 304, 531-543.
  8. Cowan BJ. Twelve Technical Strategies to the Perfect Surgical Scar. Skin Ther Lett 2005; 10, 9.
  9. Dai DL, Martinka M, Li G. Prognostic Significance of Activated Akt Expression in Melanoma: A Clinicopathologic Study of 292 Cases. J Clin Oncol 2005; 23, 1473-1482.
  10. Freyschmidt-Paul P, McElwee KJ, Hoffman R, Sundberg JP, Kissling S, Hummel S, Vitacolonna M, Kopp-Schneider A, Zoller M. Reduced Expression of Interleukin-2 Decreases the Frequency of Alopecia Areata Onset in C3H/HeJ Mice. J Invest Dermatol 2005; 125(5), 946-951.
  11. Gallagher R. Sunscreens in melanoma and skin cancer prevention. CMAJ 2005; 173(3), 244-245.
  12. Gerbrandt J. Ask the expert: Will Diet Affect My Psoriasis Over The Holidays? Psoraisis Education Program Newsletter Issue 3, 2005.
  13. Gottlieb AB, Griffiths CEM, Ho VC, Mrowietz U, Murrell DF, Ortonne JP, Todd G, Cherill R, Marks I, Emady-Azar S, Paul CF. Oral pimecrolimus in the treatment of moderate to severe chronic plaque-type psoriasis: a double-blind, multicentre, randomized, dose-finding trial. BJD June 2005;152; 1219-1227.
  14. Hamzavi I, Lui H. Using Light in Dermatology: An Update on Lasers, Ultraviolet Phototherapy, and Photodynamic Therapy. Dermatol Clin 2005;23; 199-207.
  15. Ho CK, Li G. Mutant p53 melanoma cell lines respond differently to CP-31398-induced apoptosis. Br J Dermatol 2005; 153; 900-910.
  16. Huang C, Chen S, Liu Z, Tao J, Wang C, Zhou Y. Familial bullous lichen planus (FBLP): Pedigree analysis and clinical characteristics. J Cutan Med Surg 2005; 217-222.
  17. Huang Z, Lui H, McLean DI, Korbelik M, Zeng H. Raman Spectroscopy in Combination with Background Near-infrared Autofluorescence Enhances the In Vivo Assessment of Malignant Tissues. Photocem Photobiol 2005; 81, 1219-1226.
  18. Karst AM, Dai DL, Martinka M, Li G. PUMA Expression is Significantly Reduced in Human Cutaneous Melanoma. Oncogene 2005, 24; 1111-1116.
  19. Langley RG, Ho V, Lynde C, Papp KA, Poulin Y, Shear N, et al. Recommendations for incorporating biologicals into management of moderate to severe plaque psoriasis: individualized patient approaches. J Cutan Med Surg. 2005;9 Suppl 1:18-25.
  20. Lau DP, Huang Z, Lui H, Anderson DW, Berean K, Morrison MD, Shen L, Zeng H, et al. Raman spectroscopy for optical diagnosis in the larynx: Preliminary Findings. Lasers Surg Med 2005; 37: 192-200.
  21. Lee TK, Rivers JK, Gallagher RP. Site-specific protective effect of broad spectrum sunscreen on nevus development among white schoolchildren in a randomized trial. J Am Acad Dermatol 2005; 52: 786-792.
  22. McElwee JK, Freyschmidt-Paul P, Hoffman R, Kissling S, Hummel S, Vitacolonna M, Zoller M. Transfer of CD8 Cells Induces Localized Hair Loss Whereas CD4/CD25 Cells Promote Systemic Alopecia Areata and CD4/CD25 Cells Blockade Disease Onset in the C3H/HeJ Mouse Model. J Invest Dermatol 2005;124; 947-957.
  23. McLean DI, Maddin WS. Dermatologic Therapy. Preface. Dermatol Clin 2005; 23; xi-xii.
  24. Murray CA, Zloty D, Warshawski L. The evolution of soft tissue fillers in clinical practice. Dermatol Clin 2005;23; 343-363.
  25. Oble DA, Collett E, Hsieh M, Ambjorn M, Law J, Dutz J, Teh HS. A Novel T cell receptor transgenic animal model of seborrheic dermatitis-like skin disease. J Invest Dermatol 2005;124: 151-159.
  26. Olsen EA, Messenger AG, Shapiro J, Bergfeld WF, Hordinsky MK, Roberts JL, Stough D, Washenik K, Whiting D. Evaluation and treatment of male and female pattern hair loss. J Am Acad Dermatol 2005, 52; 301-311.
  27. Papp KA, Ho V, Langley R, Lynde C, Poulin Y, Shear N, et al. Strategies for optimizing treatment with efalizumab in moderate to severe psoriasis. J Cutan Med Surg. 2005;9 Suppl 1:26-32.
  28. Purdue MP, From L, Kahn HJ, Armstrong BK, Kricker A, Gallagher RP, McLaughlin JR, Klar S, Marrett LD. Etiologic factors associated with p53 immunostaining in cutaneous malignant melanoma. Int. J. Cancer 2005: 117, 486–493.
  29. Qiang, Campos, Ho, Li. Development of a PAN-Specific, Affinity-Purified Anti-acetylated Lysine Antibody for Detection, Identification, Isolation, and Intracellular Localization of Acetylated Protein. J Immunoassay Immunochem 2005; 26: 13-23.
  30. Rivers J. Publish or Perish. J Cutan Med Surg 2005;9; 1.
  31. Rivers. The state of Canadian Health Care. Skin Cancer Fdn J 2005; XXIII 102-103.
  32. Ross EK, Shapiro J. Management of Hair Loss. Dermatol Clin 2005;23; 227-243.
  33. Ross EK, Bolduc C, Lui H, Shapiro J. Treatment of Extensive Eyebrow Alopecia Areata with Topical Latanoprost. J Am Acad Dermatol 2005;53: 1095-1096.
  34. Ross EK, Tan J, Shapiro J. Primary cicatricial alopecias. J Am Acad Dermatol 2005; 53: 1.
  35. Shear N, Langley RG, Ho V. Efalizumab, a reversible T-cell modulator for psoriasis. J Cutan Med Surg 2005; 4-9.
  36. Short MA, Lui H, McLean DI, Zeng H, Alajlan A, Chen MX. Preliminary Observations on Di erences in the Raman Spectra of Cancerous and Non-Cancerous Cells and Connective Tissue of Human Skin. SPIE Proceed 2005.
  37. Stebbing E. Ask the expert: How Can I Manage Stress Over The Holidays To Avoid Flare-Ups? Psoriasis Education Program Newsletter Issue 3, 2005.
  38. Thiessen D, Lui H, McLean DI, Zeng H. Constructing A New Spectrometer For Measuring The Excitation-Emission Matrix of Skin Autofluorescence. EEM Abstract, Cdn Assn Physics meeting, June 2005.
  39. Tyler I, Rivers JK, Shoveller JA, Blum A. Melanoma detection in British Columbia, Canada. JAAD 2005;52;48-54.
  40. Yoon HK, Sargent MA, Prendiville JS, Poskitt KJ. Cerebellar and cerebral atrophy in trichothiodystrophy. Pediatr Radiol. 2005 Oct;35(10):1019-23.
  41. Zhou Y, Dai DL, Martinka M, Mingwan S, Zhang, Y, Campos EI, Dorocicz I, Tang L, Huntsman D, Nelson C, Ho V, Li G. Osteopontin Expression Correlates with Melanoma Invasion. J Invest Dermatol 2005;124; 1044-52.


« Back to Publications & Reports

05.19.09
 
 
©2010 University of British Columbia | Terms of Use | Privacy Policy